Recently, Riillo and colleagues developed a BiTE simultaneously targeting CD1a and CD3e(epsilon), which induces activation, proliferation, and cytokine release by T-cells against CD1a+ T-ALL cells in vitro [85]. The gene discussed is CD1A; the disease is acute lymphoblastic leukemia.